<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(23)</volume><submitter>Tsai MM</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Gastric cancer (GC) is the second most prevalent cancer worldwide and the eighth most common cause of tumor-related death in Taiwan. &lt;i>Helminthostachys zeylanica&lt;/i>, a flavonoid compound, has anti-inflammatory, immunomodulatory, and anticancer effects. We examined whether an extract of &lt;i>H. zeylanica&lt;/i> (E1 and E2) has potential as a treatment for GC. &lt;b>Methods:&lt;/b> We investigated the effects (pro-apoptosis, pro-autophagy, and antiproliferation ability) of &lt;i>H. zeylanica&lt;/i>-E2 on cell viability in healthy gastric epithelial (GES-1) and GC cells (AGS and BGC823). &lt;i>H. zeylanica&lt;/i>-E2 was toxic to GC cells but had little or no toxicity to normal cells. &lt;b>Results:&lt;/b> In this study, &lt;i>H. zeylanica&lt;/i>-E2 induced apoptosis through caspase 3/7, Bcl-2, Bax, cycloox</pubmed_abstract><journal>Journal of Cancer</journal><pagination>7052-7068</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8558661</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Anticancer Effects of &lt;i>Helminthostachys zeylanica&lt;/i> Ethyl acetate Extracts on Human Gastric Cancer Cells through Downregulation of the TNF-α-activated COX-2-cPLA2-PGE&lt;sub>2&lt;/sub> Pathway.</pubmed_title><pmcid>PMC8558661</pmcid><pubmed_authors>Lin HC</pubmed_authors><pubmed_authors>Cheng CY</pubmed_authors><pubmed_authors>Yu MC</pubmed_authors><pubmed_authors>Tsai MM</pubmed_authors><pubmed_authors>Tsai CC</pubmed_authors><pubmed_authors>Lin WJ</pubmed_authors><pubmed_authors>Chu MY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Anticancer Effects of &lt;i>Helminthostachys zeylanica&lt;/i> Ethyl acetate Extracts on Human Gastric Cancer Cells through Downregulation of the TNF-α-activated COX-2-cPLA2-PGE&lt;sub>2&lt;/sub> Pathway.</name><description>&lt;b>Background:&lt;/b> Gastric cancer (GC) is the second most prevalent cancer worldwide and the eighth most common cause of tumor-related death in Taiwan. &lt;i>Helminthostachys zeylanica&lt;/i>, a flavonoid compound, has anti-inflammatory, immunomodulatory, and anticancer effects. We examined whether an extract of &lt;i>H. zeylanica&lt;/i> (E1 and E2) has potential as a treatment for GC. &lt;b>Methods:&lt;/b> We investigated the effects (pro-apoptosis, pro-autophagy, and antiproliferation ability) of &lt;i>H. zeylanica&lt;/i>-E2 on cell viability in healthy gastric epithelial (GES-1) and GC cells (AGS and BGC823). &lt;i>H. zeylanica&lt;/i>-E2 was toxic to GC cells but had little or no toxicity to normal cells. &lt;b>Results:&lt;/b> In this study, &lt;i>H. zeylanica&lt;/i>-E2 induced apoptosis through caspase 3/7, Bcl-2, Bax, cycloox</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-08T22:47:13.232Z</modification><creation>2025-08-17T03:05:29.685Z</creation></dates><accession>S-EPMC8558661</accession><cross_references><pubmed>34729107</pubmed><doi>10.7150/jca.64638</doi></cross_references></HashMap>